DY Patil Medical College Case: NRI student granted relief by the Bombay High Court

Published On 2018-06-03 06:48 GMT   |   Update On 2018-06-03 06:48 GMT

Mumbai: The Directorate General of Health Services (DGHS) was given a directive by the Bombay High Court on Wednesday to open its web portal and issue an admission letter to an NRI medical student.


A resident of Juhu, Dr. Faaria Asif Ali, 25, had sought admission to the DY Patil Medical College’s postgraduate course in dermatology, under the NRI category. Despite DGHS in a written communication dated May 19 had deemed her eligible for the course, the college had disallowed admission to her till she made a payment of Rs.50 lakh for it.


Alleging that the college asked her for an “unofficial sum” or “donation” of Rs 50 lakh in addition to the fees for an MD (dermatology) seat under the NRI quota, the postgraduate MD aspirant moved the High court against the medical college last week.

Read Also: DY Patil Medical College Demanded Rs 50 lakh Donation: MD Dermatology aspirant accuses to HC

Meanwhile, on Wednesday, the college agreed to grant admission to the petitioner. Her Advocate Anukul B. Seth, announced in court that the college had granted her permission to start attending her lectures.


Since the DGHS had not included her officially, a Division Bench comprising Justice PD Naik and Justice Nitin Sambre directed it to open the admission portal and grant Dr Ali admission formally, reported the Hindu.


The court ordered that all formalities be completed, and an assurance is given to the petitioner that her PG admission was ensured, and also see to it that they did not again block her admission.


The matter has been put up for hearing on June 11 for compliance by the DGHS.


 
Article Source : with inputs

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News